Resveratrol

Ossip Groth (Diskussion | Beiträge)
(Die Seite wurde neu angelegt: „{{up|PHA ImmunoNutrients}} {{tp|p=32412158|t=2020. Indomethacin and resveratrol as potential treatment adjuncts for SARS-CoV-2/COVID-19.|pdf=|usr=008}} {{tp|…“)

---

Aktuelle Version vom 12. April 2021, 18:35 Uhr

PHA ImmunoNutrients

32412158 2020. Indomethacin and resveratrol as potential treatment adjuncts for SARS-CoV-2/COVID-19.
32310688 2020. Biological plausibility for interactions between dietary fat, resveratrol, ACE2, and SARS-CoV illness severity.
32562826 2020. Therapeutic potential of resveratrol against emerging respiratory viral infections.
32744711 2020. Molecular modelling of the antiviral action of Resveratrol derivatives against the activity of two novel SARS CoV-2 and 2019-nCoV receptors.

32985211 2020. Potential therapeutic effects of Resveratrol against SARS-CoV-2.

33200839 2020. An approach of fatty acids and resveratrol in the prevention of COVID-19 severity.

33222316 2020. Resveratrol inhibits the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in cultured Vero cells.